Mirum Pharmaceuticals Opens Below IPO Price

Mirum Pharmaceuticals MIRM made its public debut Thursday morning, opening at $13 after being priced at $15 per share.

The shares are listed on the Nasdaq and trading under the symbol MIRM.

Mirum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Citigroup, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering. Raymond James is acting as lead manager. Roth Capital Partners is acting as co-manager.

Related Links:

Mirum Pharmaceuticals IPO: What You Need To Know

Owl Rock Capital Opens Above IPO Price